MLAB News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

ML

Mkt Cap

$685.4M

Volume

57.73K

Next Earnings

November 5th

Loading chart

ML

MLABMesa Laboratories Inc

MLAB

Pay with—

Available Balance0.00

ML

Mkt Cap

$714.8M

Volume

57.73K

Next Earnings

November 5th

Chart Financials Earnings News About Dividends Insider Filings

Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off TodayMesa Laboratories stock plummeted 19.5% on May 27, 2026, after reporting Q4 fiscal 2026 results. While the company beat expectations on adjusted operating income per share ($3.30 vs. $1.54 estimate), sales of $63.72 million fell short of Wall Street expectations by approximately $1.48 million. CEO Siddhartha Kadia is conducting an internal review and will provide full-year guidance with the Q2 report.The Motley Fool · May 27, 2026

MESA LABS DECLARES QUARTERLY DIVIDENDMesa Laboratories announced a quarterly dividend of $0.16 per share, payable on September 15, 2025, to shareholders of record as of August 29, 2025.GlobeNewswire Inc. · Jul 3, 2025

MESA LABS DECLARES QUARTERLY DIVIDENDMesa Laboratories, Inc. (MLAB) announced a regular quarterly dividend of $0.16 per share, payable on June 16, 2025. The company is a global leader in life science tools and quality control solutions for the pharmaceutical, healthcare, and medical device industries.GlobeNewswire Inc. · Apr 7, 2025

Mesa Labs Announces Second Quarter ResultsMesa Laboratories, Inc. reported its second quarter fiscal year 2025 results, with revenues increasing 8.8% year-over-year. The company's Biopharmaceutical Development and Calibration Solutions divisions saw strong growth, while the Clinical Genomics division faced headwinds in China and North America.GlobeNewswire Inc. · Nov 7, 2024

MESA LABS DECLARES QUARTERLY DIVIDENDMesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock, payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.GlobeNewswire Inc. · Oct 2, 2024

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 ResultsLAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year (“FY24”) ended March 31, 2024 (amounts in thousands).GlobeNewswire Inc. · Jun 5, 2024

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 ResultsLAKEWOOD, Colo., May 31, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously communicated. The earnings announcement has been delayed as we work to finalize our year end audit which is focused on finalizing the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to our Clinical Genomics and Biopharmaceutical Development divisions and the purchase accounting associated with the acquisition of GKE.GlobeNewswire Inc. · May 31, 2024

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024. Mesa’s Form 10-K will be filed the same day. The earnings announcement has been delayed as we finalize the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to our Clinical Genomics and Biopharmaceutical Development divisions.GlobeNewswire Inc. · May 22, 2024

DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue EstimatesDarioHealth (DRIO) delivered earnings and revenue surprises of 66.10% and 3.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 15, 2024

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue EstimatesNeuronetics (STIM) delivered earnings and revenue surprises of 18.18% and 1.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 7, 2024

to start trading

ML

MLABMesa Laboratories Inc

MLAB

Pay with—

Available Balance0.00

Your PositionYou don't own any MLAB yet.

Related Tickers

Earnings

Dividends

Ex Nov 30

Amount$0.16

PaysDec 15

Last · Aug 31Quarterly

Amount$0.16

Yield0.50%

Annual$0.64